WallStSmart
DNTH

Dianthus Therapeutics Inc.

NASDAQ: DNTH · HEALTHCARE · BIOTECHNOLOGY

$87.12
+0.47% today

Updated 2026-05-11

Market cap
$4.67B
P/E ratio
—
P/S ratio
3,497.25x
EPS (TTM)
$-4.23
Dividend yield
—
52W range
$17 – $97
Volume
1.0M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Dianthus Therapeutics Inc. (DNTH) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue—————$1.48M$6.42M$2.83M$6.24M$2.04M
Revenue growth (YoY)——————+334.8%-56.0%+120.6%-67.3%
Cost of revenue$6000.00$376000.00$875000.00$1.84M$1.98M$2.02M$147000.00$355000.00$412000.00—
Gross profit$-6000.00$-376000.00$-875000.00$-1.84M$-1.98M$1.48M$6.42M$2.83M$6.24M$2.04M
Gross margin—————100.0%100.0%100.0%100.0%100.0%
R&D$5.78M$27.90M$41.34M$57.37M$48.64M$12.61M$29.38M$32.84M$83.11M$145.64M
SG&A$3.49M$7.83M$18.62M$23.76M$28.09M$1.96M$6.74M$18.16M$24.99M$34.33M
Operating income$-9.27M$-35.73M$-59.96M$-82.97M$-78.70M$-13.09M$-29.70M$-48.17M$-101.86M$-177.93M
Operating margin—————-886.6%-462.9%-1704.7%-1633.7%-8739.3%
EBITDA$-9.26M$-35.12M$-56.64M$-74.93M$-72.96M$-13.09M$-29.56M$-47.82M$-101.45M$-177.93M
EBITDA margin—————-886.6%-460.6%-1692.1%-1627.1%-8739.3%
EBIT$-9.27M$-35.49M$-57.52M$-76.77M$-74.94M$-71.14M$-29.70M$-48.17M$-101.86M—
Interest expense$163000.00———$3.77M$3.56M————
Income tax——————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-9.43M$-35.49M$-57.52M$-76.77M$-74.94M$-13.11M$-28.48M$-43.55M$-84.97M$-162.34M
Net income growth (YoY)—-276.3%-62.1%-33.5%+2.4%+82.5%-117.2%-53.0%-95.1%-91.1%
Profit margin—————-888.1%-443.8%-1541.2%-1362.8%-7973.3%